
    
      The purpose of this 3-year study is to conduct a longitudinal investigation using motion
      analysis of gait to objectively and quantitatively assess gait characteristics of MPS IVA
      patients. Data documenting gait characteristics and abnormalities will be gathered in
      patients initiating enzyme replacement therapy.

      Inclusion criteria Individuals with MPS IVA diagnosed by enzyme or molecular studies
      Exclusion Criteria Individual with MPS IVA previously enrolled in BMN-110 Individual is
      non-ambulatory The individual is unable to complete longitudinal study visits at least yearly
    
  